Telehealth

A new partnership for Procare Ambulance isn't just about expansion. It’s a multi-million dollar bet on a model that brings the hospital to the home.

Charles Anderson analyzes CorVel's CEO transition, examining how Sarah Scott's deep institutional knowledge, coupled with Michael G. Combs' ongoing strategic role, positions the company for sustained, tech-driven market leadership and operational excellence.

Zhongchao Inc. seeks $5M in a 'best efforts' deal, but the move sends its stock plummeting over 50% as investors weigh dilution and delisting risks.

Everlight's 800 radiologists will use Sirona's cloud-native AI platform, transforming diagnostics for millions in a landmark five-year global deal.

A new telehealth platform offers popular weight loss drugs for $149/month, but there's a catch: they aren't FDA-approved. Here's what you need to know.

Groundbreaking research on new drug classes, the gut-brain axis, and personalized medicine will be unveiled at the upcoming American Headache Society meeting.

Therini Bio's novel drug THN391 enters trials, targeting inflammation in diabetic eye disease, while a next-gen combo therapy aims to redefine care.

The radiology platform's new accreditation enables delegated credentialing, helping hospitals combat radiologist shortages and streamline critical care delivery.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

Free skin cancer screenings in Ottawa highlight a national health crisis as wait times soar and experts demand urgent government action on specialist care.

Wellness brand Le-Vel is launching a telehealth service for prescription peptides, blurring the lines between direct sales and mainstream medicine.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.

An aging continent and chronic illness are fueling a pharmacy boom in Europe, but success hinges on navigating a maze of regulations and winning the digital race.

A Canadian pilot's daring evacuation in the DRC highlights a new Ebola crisis, as a rare, untreatable strain spreads through the conflict-ridden region.

Ionetix wins FDA approval for its generic prostate cancer imaging agent, a move set to boost access and shake up the competitive radiopharmaceutical market.

Following its X3D acquisition, Catalyst MedTech unveils an expanded portfolio and a new strategy to tackle aging equipment and modernize nuclear medicine.

With the hire of Loïc Juillard, TailorCare signals a major push to scale its AI-driven platform in the competitive musculoskeletal care market.

A new report reveals Europe's medically-focused cannabis market is finally waking, creating a new global blueprint but also intense competition and price wars.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

A new telehealth platform offers prescription-only CBD, navigating a major regulatory shift that will reshape the entire cannabis industry. Here's what's next.